Alles für Unternehmen
Ethical is a company that specializes in the development and implementation of eClinical solutions, with a particular focus on eAdjudication®. Our team has extensive experience in various aspects of the eClinical industry, including eClinical technology, clinical systems, data management in global trials, clinical trial quality, and data compliance. We have also worked closely with academic research organizations, biopharmaceutical and medical device companies, clinical research organizations, and independent review committees.
Our expertise lies in the creation, execution, and management of Endpoint Adjudication processes. We have developed a managed software service, eAdjudication®, which is built on a robust enterprise technology platform. This platform supports all aspects of endpoint adjudication committee management and ensures adherence to best practices, quality control, and regulatory compliance. Our software seamlessly integrates with any Electronic Data Capture (EDC) system and can be tailored to meet the specific needs of any study, phase, or regulatory requirements.
At Ethical, we are dedicated to optimizing the eAdjudication® process for every client. We provide comprehensive support, including workflows and forms validation, private health information management, clinical trial and GxP compliance, clinical systems design and integration, as well as web and mobile interface design. Our goal is to offer a flexible and adaptable solution that meets the unique requirements of each project.
In summary, Ethical is a leading provider of eAdjudication® solutions in the eClinical industry. Our experienced team, coupled with our state-of-the-art software and commitment to quality, makes us the ideal partner for organizations seeking efficient and reliable endpoint adjudication management.
Diese Website verwendet Cookies und andere Besucherkennungen für die Bequemlichkeit eines jeden Benutzers. Wenn Sie nach dem Lesen dieser Nachricht auf unserer Website bleiben, bedeutet dies, dass Sie keine Einwände gegen die Verwendung dieser Technologien haben. Mehr Informationen